Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Nanfang Hospital, Southern Medical University is the lead sponsor of 142 current clinical trials in our China register. 94 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Anlotinib, Bevacizumab and Luspatercept. The most-studied condition is Gastric Cancer.

ClinicalTrials.gov trials by status

Recruiting9466%
Not yet open3122%
Active, closed107%
By invitation75%

Trials by phase

Observational6646%
Not applicable3726%
Phase 22014%
Phase 486%
Phase 2/343%
Phase 332%
Phase 121%
Phase 1/211%
Phase EARLY_PHASE111%

Clinical trials sponsored by Nanfang Hospital, Southern Medical University

142 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Novel Humanized Ferritin-Based NIR Fluorescent Probe for Identifying Sentinel Lymph Node Metastasis in Early Gastric Cancer NCT07294638 · Gastric Cancer, Molecular Imaging	Observational	Recruiting	2025-07	China
Non-invasive Tools for PSVD Diagnosis NCT06500403 · Non-Cirrhotic Portal Hypertension, Porto-Sinusoidal Vascular Diseases	Observational	Recruiting	2024-02	China
Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis NCT07622667 · ClinicalTrials.gov ↗ · Malignant Tumors	Observational	Recruiting	2026-05	China
Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant Radiotherapy NCT06902051 · ClinicalTrials.gov ↗ · Breast Cancer Early Stage Breast Cancer (Stage 1-3)	Not applicable	Recruiting	2025-04	China
Effect of Low-dose EsketaMine on dElirium in High-risk Elderly Patients uNdergoing elecTive Surgery (ELEMENT) NCT06817239 · ClinicalTrials.gov ↗ · Delirium in Old Age, Delirium, Postoperative, Anesthesia Drug: Esketamine	Not applicable	Recruiting	2025-02	China
Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC. NCT06327178 · ClinicalTrials.gov ↗ · Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC	Observational	Recruiting	2023-10	China
Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction NCT07263711 · ClinicalTrials.gov ↗ · Glioma	Observational	Recruiting	2025-09	China
Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma NCT07819656 · ClinicalTrials.gov ↗ · Nasopharyngeal Carcinoma (NPC), Myelosuppression	Observational	Recruiting	2026-08	China
Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas NCT07744087 · ClinicalTrials.gov ↗ · Ampullary Carcinoma, Duodenal Adenocarcinoma, Distal Cholangiocarcinoma	Not applicable	Recruiting	2026-06	China
Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer NCT07239063 · ClinicalTrials.gov ↗ · CRC (Colorectal Cancer), Lung Cancer (Diagnosis)	Observational	Recruiting	2024-10	China
Bidirectional Cohort Study of Nanfang Spondyloarthritis NCT06988813 · ClinicalTrials.gov ↗ · Spondyloarthritis (SpA), Ankylosing Spondylitis (AS)	Observational	Recruiting	2025-05	China
Association of Lifestyle With Complications in the Diabetic Population NCT06903364 · ClinicalTrials.gov ↗ · Diabetes Mellitus	Observational	Recruiting	2024-08	China
Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma NCT06885814 · ClinicalTrials.gov ↗ · Esophageal Squamous Cell Carcinoma	Phase 2	Recruiting	2024-06	China
Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma NCT06298968 · ClinicalTrials.gov ↗ · Intrahepatic Cholangiocarcinoma	Phase 2	Recruiting	2024-04	China
Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation NCT07608120 · ClinicalTrials.gov ↗ · Colonoscopy, Bowel Preparation Solutions, Colorectal Cancer Screening	Not applicable	Recruiting	2026-05	China
The Role of Skin Microecology in Diabetic Skin Lesions NCT04916457 · ClinicalTrials.gov ↗ · Diabetic Foot, Diabetic Dermopathy	Observational	Recruiting	2020-12	China
PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer NCT07775820 · ClinicalTrials.gov ↗ · Lung Cancer, Rechallenge, Checkpoint Inhibitor Pneumonitis	Observational	Recruiting	2025-10	China
Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors NCT07759960 · ClinicalTrials.gov ↗ · Rectal Neuroendocrine Tumor	Not applicable	Recruiting	2026-04	China
A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China NCT04573283 · ClinicalTrials.gov ↗ · Metabolic Associated Fatty Liver Disease	Observational	Recruiting	2020-08	China
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy NCT06276088 · ClinicalTrials.gov ↗ · Immunotherapy, Hyperprogression, Biomarker	Observational	Recruiting	2024-02	China
Modified Intermittent Eating on Weight Loss (INTEREST-3 Trial) NCT06302803 · ClinicalTrials.gov ↗ · Obesity	Not applicable	Recruiting	2024-04	China
REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry NCT05728775 · ClinicalTrials.gov ↗ · Anesthesia, Surgery-Complications	Phase 4	Recruiting	2023-04	China
The Role and Regulatory Mechanism of Germinal Center Immune Response in Hepatitis B Virus Infection NCT07240350 · ClinicalTrials.gov ↗ · Hepatitis B Virus Infection	Observational	Recruiting	2021-01	China
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening NCT07032961 · ClinicalTrials.gov ↗ · Gastritis, Gastric Dysplasia, Gastric Ulcer	Observational	Recruiting	2025-06	China
Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer NCT07003334 · ClinicalTrials.gov ↗ · Gastric Cancers	Observational	Recruiting	2025-01	China
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia NCT06155188 · ClinicalTrials.gov ↗ · Leukemia, Stem Cell Transplant, Cord Blood	Not applicable	Recruiting	2019-09	China
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease NCT07265544 · ClinicalTrials.gov ↗ · Liver Neoplasm, HBV Infection, Non-alcoholic Fatty Liver Disease NAFLD	Observational	Recruiting	2023-03	China
PEI-GT Trial for Initial Treatment of Primary Open-Angle Glaucoma With Cataract NCT07700498 · ClinicalTrials.gov ↗ · Primary Open Angle Glaucoma and Cataracts	Not applicable	Recruiting	2026-07	China
Improvement of Depression With Use of ATP NCT06266715 · ClinicalTrials.gov ↗ · Depression	Not applicable	Recruiting	2024-03	China
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC NCT06177925 · ClinicalTrials.gov ↗ · Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by Site Drugs: Adebrelimab, Etoposide, Ivonescimab	Phase 2	Recruiting	2023-12	China
Immune Dynamics in the Natural History of Chronic HBV Infection NCT07137247 · ClinicalTrials.gov ↗ · HBV (Hepatitis B Virus), HBV Infection, Chronic Hep B	Observational	Recruiting	2024-02	China
Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma NCT06017895 · ClinicalTrials.gov ↗ · Swallowing-induced Pain	Not applicable	Recruiting	2023-10	China
SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury NCT06173947 · ClinicalTrials.gov ↗ · End Stage Liver Disease, Jaundice, Liver Dysfunction	Observational	Recruiting	2024-01	China
Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer. NCT04850729 · ClinicalTrials.gov ↗ · Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma	Observational	Recruiting	2021-05	China
Pathogenic Metagenomic Next-generation Sequencing to Optimize the Diagnosis of Decompensated Cirrhosis Infection NCT06039696 · ClinicalTrials.gov ↗ · Cirrhosis, Liver	Observational	Recruiting	2021-02	China
Early Complications After Flow Diverter Versus Stent-Assisted Coiling for Unruptured Wide-Neck Intracranial Bifurcation Aneurysms NCT07754188 · ClinicalTrials.gov ↗ · Unruptured Intracranial Aneurysm, Intracranial Bifurcation Aneurysm, Wide-Neck Aneurysm	Observational	Recruiting	2026-03	China
nVNS for the Prevention and Treatment of Primary Headache NCT06277063 · ClinicalTrials.gov ↗ · Primary Headache, Migraine in Adolescence, Migraine in Children	Not applicable	Recruiting	2024-12	China
Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis NCT06307314 · ClinicalTrials.gov ↗ · Nasopharyngeal Carcinoma, Head and Neck Cancer, Radiotherapy-induced Oral Mucositis	Observational	Recruiting	2024-02	China
Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore NCT06157996 · ClinicalTrials.gov ↗ · Gastric Cancer Drug: Tislelizumab	Phase 2	Recruiting	2024-06	China
Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy NCT07604311 · ClinicalTrials.gov ↗ · IgA Nephropathy (IgAN)	Phase 4	Recruiting	2026-06	China
Plantar Stimulation, Whole-Body Vibration, and Baduanjin for Muscle Activation NCT07811674 · ClinicalTrials.gov ↗ · Flat Feet, Lower-Limb Muscle Activation, Neuromuscular Response	Not applicable	Recruiting	2026-09	China
EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC NCT07637448 · ClinicalTrials.gov ↗ · Lung Cancer Non-Small Cell Cancer (NSCLC), EGFR Activating Mutation, PD-1 Antibody	Phase 2	Recruiting	2026-05	China
Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL NCT07203352 · ClinicalTrials.gov ↗ · Acute Lymphoblastic Leukemia	Phase 3	Recruiting	2025-10	China
Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma NCT06970145 · ClinicalTrials.gov ↗ · Craniopharyngiomas Drug: Anlotinib	Phase 1/2	Recruiting	2025-04	China
Prospective Pathology Foundation Models NCT07157618 · ClinicalTrials.gov ↗ · Pancancer	Observational	Recruiting	2025-08	China
Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy NCT07436845 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma (HCC), Emotional Distress, HAIC(Hepatic Artery Infusion Chemotherapy)	Observational	Recruiting	2025-12	China
Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study NCT07539792 · ClinicalTrials.gov ↗ · Sellar Tumor, Endonasal Surgery, Csf Leakage	Phase 2	Recruiting	2026-04	China
Exploring the Diagnostic Performance of Dynamic Chest Radiology in Chronic Obstructive Pulmonary Disease NCT06653413 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease (COPD)	Observational	Recruiting	2024-01	China
A Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis NCT06287788 · ClinicalTrials.gov ↗ · Radiation-induced Oropharyngeal Mucositis, Swallowing-induced Breakthrough Pain	Observational	Recruiting	2024-03	China
Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules NCT06823895 · ClinicalTrials.gov ↗ · Healthy	Phase 1	Recruiting	2024-09	China
Efficacy and Safety of Anlotinib Combined With Bemocizumab for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma(ESCC) NCT07627347 · ClinicalTrials.gov ↗ · ESCC Drugs: Anlotinib, Bevacizumab	Not applicable	Recruiting	2026-05	China
Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis NCT06307327 · ClinicalTrials.gov ↗ · Head and Neck Cancer, Radiation-Induced Mucositis	Observational	Recruiting	2025-09	China
Tissue-resident Immune Cell Subsets in aGVHD NCT06708507 · ClinicalTrials.gov ↗ · Acute Graft-versus-Host Disease, Hematopoietic Stem Cell Transplantation	Observational	Recruiting	2024-11	China
Early Warning and Intervention Mechanism of Foot Health Risk in Children and Adolescents NCT06581978 · ClinicalTrials.gov ↗ · Flexible Flatfoot	Not applicable	Recruiting	2024-01	China
Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma NCT05214222 · ClinicalTrials.gov ↗ · Advanced Esophageal Squamous Cell Carcinoma	Phase 2	Recruiting	2022-09	China
A Multicenter, Prospective, Randomized Controlled Study on EUS-Guided Precise Disconnection of Varices Versus Endoscopic Gastric Variceal Glue Injection for the Prevention of Gastric Variceal Bleeding. NCT07532915 · ClinicalTrials.gov ↗ · Gastric Variceal	Not applicable	Recruiting	2025-10	China
QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT NCT07327788 · ClinicalTrials.gov ↗ · Hepatecellular Carcinoma, RALOX-HAIC（Hepatic Arterial Infusion Chemotherapy With Raltitrexed and Oxaliplatin, Bevacizumab Drugs: Bevacizumab, Iparomlimab and Tuvonralimab	Phase 2	Recruiting	2025-12	China
OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method NCT05450835 · ClinicalTrials.gov ↗ · Gastric Cancer	Not applicable	Recruiting	2022-09	China
Chronic Kidney Disease-related Sarcopenia With Poor Prognosis NCT05353660 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases, Sarcopenia	Observational	Recruiting	2022-04	China
Sonic vs Passive Ultrasonic Irrigation for Chronic Apical Periodontitis NCT07069881 · ClinicalTrials.gov ↗ · Chronic Apical Periodontitis	Not applicable	Recruiting	2024-12	China
Clinical Outcomes After Non-curative Endoscopic Resection in Early Colorectal Cancer: A Multicenter Study NCT07542171 · ClinicalTrials.gov ↗ · Early Colorectal Cancer, Non-curative Endoscopic Resection	Observational	Recruiting	2025-09	China
Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma NCT06864221 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma, Radiotherapy, Treatment Outcome	Observational	Recruiting	2024-09	China
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios NCT06848400 · ClinicalTrials.gov ↗ · Gastric Lesion, Gastritis, Upper Gastrointestinal Bleeding (UGIB)	Not applicable	Recruiting	2025-03	China
The Outcome of Chronic Kidney Disease Patients With Obstructive Sleep Apnea Syndrome NCT06971874 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases, OSAS (Obstructive Sleep Apneas Syndrome)	Observational	Recruiting	2025-07	China
Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of Thromboelastography NCT06736860 · ClinicalTrials.gov ↗ · Trauma Coagulopathy Drug: Tranexamic acid (TXA)	Phase 4	Recruiting	2024-08	China
Comparison of the Efficacy and Safety of Ciprofol Versus Propofol for Sedation in ICU Patients Undergoing Non-Invasive Ventilation NCT07536750 · ClinicalTrials.gov ↗ · Respiratory Failure, Critical Illness	Observational	Recruiting	2025-11	China
Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis NCT06707194 · ClinicalTrials.gov ↗ · Spondyloarthritis (SpA), Ankylosing Spondylitis (AS) Drug: Etanercept	Phase 4	Recruiting	2025-06	China
Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis NCT05644314 · ClinicalTrials.gov ↗ · Ischemic Stroke, Vertebral Artery Stenosis	Not applicable	Recruiting	2022-05	China
HBsAg Declined Patients Follow-up Study NCT05977283 · ClinicalTrials.gov ↗ · Hepatitis B, Hepatitis B, Chronic	Observational	Recruiting	2023-05	China
A Multicenter Study Based on Multi-omics Analysis to Predict the Early Prognosis and Recurrence Risk of Acute Ischemic Stroke NCT06584565 · ClinicalTrials.gov ↗ · Ischemic Stroke, Acute	Observational	Recruiting	2024-01	China
A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL NCT06220487 · ClinicalTrials.gov ↗ · Acute Lymphoblastic Leukemia, Philadelphia Chromosome, Philadelphia-Positive ALL	Phase 2	Recruiting	2024-02	China
A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis NCT06308328 · ClinicalTrials.gov ↗ · Radiation-induced Oropharyngeal Mucositis, Swallowing-induced Breakthrough Pain	Observational	Recruiting	2024-04	China
Prediction of Vascular Events After Major Non-Cardiac Surgery : an Observational Prospective Cohort Study NCT05812248 · ClinicalTrials.gov ↗ · Noncardiac Surgery	Observational	Recruiting	2022-07	China
Correlation and Predictive Research of Metal Elements in Radiation-Induced Oral Mucositis NCT06968520 · ClinicalTrials.gov ↗ · Head and Neck Tumors, Metal, Copper	Observational	Recruiting	2025-04	China
HVA vs IA/DA or VA in the Treatment of ND HR-AML NCT06810791 · ClinicalTrials.gov ↗ · Newly Diagnosed Acute Myeloid Leukemia With High Risk	Phase 3	Recruiting	2025-01	China
Targeted Optical Biopsy for Local Rectal Scars in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy NCT05316103 · ClinicalTrials.gov ↗ · Rectal Cancer	Not applicable	Recruiting	2021-11	China
Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody NCT05392413 · ClinicalTrials.gov ↗ · Esophageal Squamous Cell Carcinoma, PD-1 Inhibitor	Observational	Recruiting	2022-08	China
Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma NCT06623474 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma	Observational	Recruiting	2024-07	China
Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation NCT07693881 · ClinicalTrials.gov ↗ · EBV Infection After Allogenic HSCT Drug: Rituximab	Not applicable	Recruiting	2026-07	China
PeRsonalized Blood prEssure Management on Postoperative Complications and Mortality in hIgh-risk Patients Undergoing Major Non-cardiac Surgery NCT06952387 · ClinicalTrials.gov ↗ · Hypotension	Not applicable	Recruiting	2025-06	China
Sepsis-associated Thrombocytopenia and Platelet Transfusion （STAPT） NCT07230067 · ClinicalTrials.gov ↗ · Sepsis, Sepsis and Coagulopathy	Observational	Recruiting	2025-11	China
Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study NCT07762573 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease	Observational	Recruiting	2026-08	China
Optical Biopsy for Peritoneal Nodules in Colorectal Patients NCT05879783 · ClinicalTrials.gov ↗ · Colorectal Cancer	Not applicable	Recruiting	2022-09	China
Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer NCT05494086 · ClinicalTrials.gov ↗ · Gastric Cancer	Not applicable	Recruiting	2022-08	China
Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI NCT05545605 · ClinicalTrials.gov ↗ · Ischemic Stroke Drug: Sodium Oligomannate	Not applicable	Recruiting	2023-04	China
Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study NCT07539727 · ClinicalTrials.gov ↗ · Inflammatory Bowel Diseases	Observational	Recruiting	2025-01	China
Clinical Trial of Modified Endocrown and Personalized Post-core and Crown for Large-area Tooth Defects After Root Canal Treatment NCT07206108 · ClinicalTrials.gov ↗ · Root Canal Infection, Tooth Defect, Post and Core Technique	Not applicable	Recruiting	2025-08	China
Association of Inflammatory Factors With Complications in the Diabetic Population: a Cross-sectional Study NCT06651983 · ClinicalTrials.gov ↗ · Diabetes Mellitus	Observational	Recruiting	2025-06	China
Breathomics in the Diagnosis and Prediction of Radiotherapy-Induced Oropharyngeal Mucositis in Head and Neck Tumors NCT06767488 · ClinicalTrials.gov ↗ · Head and Neck Tumors, Breathomics, Volatile Organic Compounds	Observational	Recruiting	2024-12	China
Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients NCT05825443 · ClinicalTrials.gov ↗ · Immunotherapy, Chemotherapy	Phase 2	Recruiting	2023-04	China
Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma NCT03919552 · ClinicalTrials.gov ↗ · Cisplatin, Carboplatin, NPC	Phase 3	Recruiting	2018-01	China
A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma NCT06843889 · ClinicalTrials.gov ↗ · Locally Advanced Esophageal Squamous Cell Carcinoma Drug: Toripalimab	Phase 2	Recruiting	2025-04	China
Flow Diverter Versus Conventional Endovascular Treatment for Unruptured Wide-Neck Bifurcation Aneurysms (FD-BWA Trial) NCT07707076 · ClinicalTrials.gov ↗ · Unruptured Intracranial Wide-neck Bifurcation Aneurysms	Not applicable	Recruiting	2026-02	China
PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer NCT06429696 · ClinicalTrials.gov ↗ · Small Cell Lung Cancer Extensive Stage	Phase 2	Recruiting	2024-07	China
Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma NCT07603349 · Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma	Phase 2/3	Not yet open	2026-06	China
Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Treatment of Ischemic Stroke NCT07604298 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Observational	Not yet open	2026-07	China
Association of Prophylactic Use of Stress Ulcer Drugs and Clinical Outcomes in Patients With Acute Anterior Circulation Thrombectomy NCT05845372 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Observational	Not yet open	2023-05	China
Study on the Correlation and Consistency of Measuring Biologic Drug Plasma Concentrations Based on Different Detection Methods NCT06849739 · ClinicalTrials.gov ↗ · Inflammatory Bowel Diseases	Observational	Not yet open	2025-03	China
A Randomized Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of Things NCT07126457 · ClinicalTrials.gov ↗ · Head and Neck Cancer, Radiation-Induced Mucositis	Not applicable	Not yet open	2025-09	China
A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy NCT07091994 · ClinicalTrials.gov ↗ · Ischemic Stroke, Acute, Active Malignancies Drug: Edaravone Dexborneol	Phase 4	Not yet open	2026-08	China

Showing the 100 most recently updated of 142 trials (recruiting first). The rest are in the country registers linked in each row.

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Nanfang Hospital, Southern Medical University trials

32 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Conditions in Nanfang Hospital, Southern Medical University trials

222 conditions

Gastric Cancer8 Acute Ischemic Stroke4 Immunotherapy4 Head and Neck Cancer3Biomarker3Hematological Malignancies3Pancancer3Hepatocellular Carcinoma (HCC)3Molecular Imaging2Gastric Adenocarcinoma2 Gastroesophageal Junction Adenocarcinoma2 Anesthesia2 Inflammatory Bowel Diseases2Radiation-Induced Mucositis2Ischemic Stroke, Acute2Spondyloarthritis (SpA)2Ankylosing Spondylitis (AS)2Diabetes Mellitus2 Esophageal Squamous Cell Carcinoma2Gastritis2Gastric Dysplasia2HBV Infection2Radiotherapy-induced Oral Mucositis2Luspatercept2

By trial register

Register	Trials	Recruiting
Clinical trials in China	142	94

A trial with sites in more than one country appears in each of those registers; recruiting counts cover the trials listed on this page.

Other sponsors in Gastric Cancer

Sponsor	Trials
Fujian Medical University	9
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	6
The First Affiliated Hospital with Nanjing Medical University	5
Chongqing Precision Biotech	4
RemeGen	3
Yunnan Cancer Hospital	3
TORL Biotherapeutics	2
Merus	2
Ono Pharmaceutical	2
Wuhan University	2

Sponsors with the most current trials registered for this condition.

Questions about Nanfang Hospital, Southern Medical University trials

How many clinical trials does Nanfang Hospital, Southern Medical University sponsor?

Nanfang Hospital, Southern Medical University is the lead sponsor of 142 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Nanfang Hospital, Southern Medical University trials recruiting?

Yes. 94 of its 142 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Nanfang Hospital, Southern Medical University testing?

Its current trials name 32 drugs and biologicals as interventions. The most frequent are Anlotinib (4), Bevacizumab (2), Luspatercept (2), Adebrelimab (1) and Alirocumab (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Nanfang Hospital, Southern Medical University clinical trials